📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasome. (2023)

First Author: Ossola B

Attributed to: New insights into NLRP3 within inflammatory disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.neuropharm.2022.109330

PubMed Identifier: 36375694

Publication URI: http://europepmc.org/abstract/MED/36375694

Type: Journal Article/Review

Volume: 224

Parent Publication: Neuropharmacology

ISSN: 0028-3908